South Korea · Delayed Price · Currency is KRW Ligand Pharmaceuticals Statistics
Total Valuation
KOSDAQ:011040 has a market cap or net worth of KRW 163.81 billion. The enterprise value is 167.69 billion.
| Market Cap | 163.81B |
| Enterprise Value | 167.69B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KOSDAQ:011040 has 26.94 million shares outstanding. The number of shares has decreased by -0.66% in one year.
| Current Share Class | 26.94M |
| Shares Outstanding | 26.94M |
| Shares Change (YoY) | -0.66% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 43.84% |
| Owned by Institutions (%) | 0.81% |
| Float | 12.19M |
Valuation Ratios
The trailing PE ratio is 28.17.
| PE Ratio | 28.17 |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | 38.95 |
| P/OCF Ratio | 12.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.54, with an EV/FCF ratio of 39.88.
| EV / Earnings | 28.84 |
| EV / Sales | 0.86 |
| EV / EBITDA | 16.54 |
| EV / EBIT | 32.22 |
| EV / FCF | 39.88 |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.22 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 3.67 |
| Debt / FCF | 8.61 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 2.69% and return on invested capital (ROIC) is 1.23%.
| Return on Equity (ROE) | 2.69% |
| Return on Assets (ROA) | 1.03% |
| Return on Invested Capital (ROIC) | 1.23% |
| Return on Capital Employed (ROCE) | 2.25% |
| Revenue Per Employee | 556.18M |
| Profits Per Employee | 16.61M |
| Employee Count | 350 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | -63.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.15% in the last 52 weeks. The beta is 0.68, so KOSDAQ:011040's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -7.15% |
| 50-Day Moving Average | 6,031.00 |
| 200-Day Moving Average | 5,962.50 |
| Relative Strength Index (RSI) | 52.39 |
| Average Volume (20 Days) | 24,533 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:011040 had revenue of KRW 194.66 billion and earned 5.81 billion in profits. Earnings per share was 215.82.
| Revenue | 194.66B |
| Gross Profit | 116.01B |
| Operating Income | 4.92B |
| Pretax Income | 5.72B |
| Net Income | 5.81B |
| EBITDA | 9.85B |
| EBIT | 4.92B |
| Earnings Per Share (EPS) | 215.82 |
Balance Sheet
The company has 32.58 billion in cash and 36.21 billion in debt, giving a net cash position of -3.62 billion or -134.48 per share.
| Cash & Cash Equivalents | 32.58B |
| Total Debt | 36.21B |
| Net Cash | -3.62B |
| Net Cash Per Share | -134.48 |
| Equity (Book Value) | 213.99B |
| Book Value Per Share | 7,932.90 |
| Working Capital | 17.64B |
Cash Flow
In the last 12 months, operating cash flow was 12.87 billion and capital expenditures -8.67 billion, giving a free cash flow of 4.21 billion.
| Operating Cash Flow | 12.87B |
| Capital Expenditures | -8.67B |
| Free Cash Flow | 4.21B |
| FCF Per Share | 156.08 |
Margins
Gross margin is 59.60%, with operating and profit margins of 2.53% and 2.99%.
| Gross Margin | 59.60% |
| Operating Margin | 2.53% |
| Pretax Margin | 2.94% |
| Profit Margin | 2.99% |
| EBITDA Margin | 5.06% |
| EBIT Margin | 2.53% |
| FCF Margin | 2.16% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 4.93%.
| Dividend Per Share | 300.00 |
| Dividend Yield | 4.93% |
| Dividend Growth (YoY) | -25.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 186.65% |
| Buyback Yield | 0.66% |
| Shareholder Yield | 5.64% |
| Earnings Yield | 3.55% |
| FCF Yield | 2.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 20, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Apr 20, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
KOSDAQ:011040 has an Altman Z-Score of 2.83 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.83 |
| Piotroski F-Score | 6 |